Your Path to Hope Resources

Novocure and GT Medical Technologies continue to move forward and make progress in their research to creating a better quality of life for patients and improving survival rates.

Initiated by the nonprofit, OurBrainBank, Brains for the Cure and many other advocacy groups, including Head for the Cure, are honored to present the Glioblastoma Bill of Rights. It is estimated that 87,000 people will …

Written by: Courtney Benisch – Regional Relationship Coordinator for Head for the Cure This year has been nothing but a roller coaster, and as a caregiver, I cannot even imagine what it is like watching …

Dr. Khagi from UNC Neuro-Oncology Program breaks down a glioblastoma diagnosis from imaging to clinical trials to new research.

Head for the Cure RRC, Courtney Benisch, tried her best to stay positive throughout her mother’s treatment and passing, and encourages how you can do the same.

Written by Head for the Cure Ambassador, Dr. Simon Khagi. Dr. Khagi is an Assistant Professor of Medicine and Neurosurgery at the University of North Carolina, Director of the UNC Neuro-Oncology Program, and the Director …

Earlier today, GT Medical Technologies of Tempe, Arizona announced patients with newly diagnosed malignant tumors are now eligible to receive FDA-cleared GammaTile® Therapy in addition to patients with recurrent brain tumors.

Learn side effects for common brain cancer drugs, like Temodar, Avastin, Lomustine, and others.

Rep. Crossman sponsored the House Bill 230 proposing May as Brain Cancer Awareness Month in the state of Ohio.

Just outside the boundaries of a brain tumor is the tumor microenvironment, full of cells that the tumor recruits to grow and elude treatments. Scientists are looking at ways to battle back.